Stantec
STN · TORONTO
About STN
- Employees
- 34,000
- Headquarters
- Edmonton, Alberta
- Listed
- Mar 30, 1994
- Sector
- Industrials
- Industry
- Construction & Engineering
- Website
- stantec.com
STN key statistics
- Market cap
- 11.48B
- Price-earnings ratio
- 23.38
- Dividend yield
- 0.91%
- Average volume
- 351.85K
- Volume
- 366.13K
- Open price
- $72.21
- High today
- $72.47
- Low today
- $70.71
- 52 Week high
- $114.52
- 52 Week low
- $65.35
Stantec (STN) at a glance
Stantec (STN) last traded at $71.11, with a market cap of 11.48B, a price-to-earnings ratio of 23.38 and a dividend yield of 0.91%.
Today the stock has traded between $70.71 and $72.47. The current price is 0.6% above the day's low and 1.9% below its high.
Volume so far is 366.13K shares, in line with the average of 351.85K shares a day.
Over the past year Stantec has ranged from $65.35 to $114.52, and now sits 12% of the way up that range.
Stantec met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.61 per share against an estimate of $1.60.
The average analyst price target is $99.88, 40.5% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $81.30
- Now
- $71.11
- High
- $126.41
STN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 3.7% on average.
- Q3 FY24: reported $1.30 per share against an estimate of $1.26
- Q4 FY24: reported $1.11 per share against an estimate of $1.01
- Q1 FY25: reported $1.16 per share against an estimate of $1.12
- Q2 FY25: reported $1.36 per share against an estimate of $1.38
- Q3 FY25: reported $1.53 per share against an estimate of $1.55
- Q4 FY25: reported $1.25 per share against an estimate of $1.23
- Q1 FY26: reported $1.33 per share against an estimate of $1.31
- Q2 FY26: reported $1.61 per share against an estimate of $1.60
STN news
- Press releaseGlobe Newswire
Stantec Receives TSX Approval To Increase Its Maximum Normal Course Issuer Bid Volume From 2,281,339 Shares To 5,703,349 Shares
- Press releaseGlobe Newswire
Stantec announces amendment to Normal Course Issuer Bid
- Press releaseGlobe Newswire
Stantec delivers strong second quarter 2026 results, expands margins and raises adjusted EBITDA outlook for 2026
- Press releaseGlobe Newswire
Stantec joint venture selected by U.S. Army Corps of Engineers to advance coastal resilience on Charleston’s peninsula
- Press releaseGlobe Newswire
Stantec to release second quarter 2026 results on August 12, 2026 and host conference call on August 13, 2026
- Press releaseGlobe Newswire
Gord Johnston to Transition to Vice Chair of Stantec's Board of Directors
- Press releaseBusiness Wire
Black & Veatch-Stantec Joint Venture to lead U.S. Army Corps of Engineers Brandon Road Interbasin ecosystem protection project
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.